RxSight RXST
NASDAQ RXST
$4.90 +0.02 (+0.41%)
At close: Oct 21, 2026 · 4:00 PM EDT

RxSight (RXST) Current Deferred Revenue (2025 - 2026)

Updated

RxSight (RXST) recorded Current Deferred Revenue of $6.88 million in Q2 2026.

Analysis

RxSight (RXST) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, RxSight reported Current Deferred Revenue of $3.26 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 RxSight 204.14 Mn -4.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.88 Mn
Dec 31, 2025 3.26 Mn
API Access

RxSight Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RXST&period=max&api_key=YOUR_API_KEY